<?xml version="1.0" encoding="UTF-8"?>
<p id="par0150">We also support the possibility of using on- line affinity columns for removing either the COVID 19 virus itself or its antibodies from the circulation of donors or patients. This process has been recently successfully achieved for hemophilia B patients, with a very high titter of antibodies to Factor IX in Malmo Sweden. t this approach could be used for COVID patients with various matrixes to selectively remove the antigen or the antibodies, according to need and the column could be subsequently desorbed to obtain purer substances.</p>
